EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility

Xing-An Wang, Ju-Pi Li iD, Kang-Hsi Wu iD, Shun-Fa Yang iD, Yu-Hua Chao iD

International Journal of Molecular Sciences · 24.02.2023 · 24 (5) · 4464

DOI: 10.3390/ijms24054464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.02.2023. Verfasst von Xing-An Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402, Taiwan. Hauptthemen laut MEDLINE: Anemia, Aplastic, Pancytopenia, Mesenchymal Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Chung Shan Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aplastic anemia (AA), a rare but potentially life-threatening disease, is a paradigm of bone marrow failure syndromes characterized by pancytopenia in the peripheral blood and hypocellularity in the bone marrow. The pathophysiology of acquired idiopathic AA is quite complex. Mesenchymal stem cells (MSCs), an important component of the bone marrow, are crucial in providing the specialized microenvironment for hematopoiesis. MSC dysfunction may result in an insufficient bone marrow and may be associated with the development of AA. In this comprehensive review, we summarized the current understanding about the involvement of MSCs in the pathogenesis of acquired idiopathic AA, along with the clinical application of MSCs for patients with the disease. The pathophysiology of AA, the major properties of MSCs, and results of MSC therapy in preclinical animal models of AA are also described. Several important issues regarding the clinical use of MSCs are discussed finally. With evolving knowledge from basic studies and clinical applications, we anticipate that more patients with the disease can benefit from the therapeutic effects of MSCs in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticPancytopeniaMesenchymal Stem CellsAnimalsBone Marrow

Stichwörter der Autor:innen

aplastic anemiabone marrow failurecell therapymesenchymal stem cells

Autor:innen und Institutionen

  • Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Clinical Pathology, Chung Shan Medical University Hospital, Taichung 402, Taiwan.

ORCID-Profile: Ju-Pi Li, Kang-Hsi Wu, Shun-Fa Yang, Yu-Hua Chao

Förderung

  • Ministry of Science and Technology
  • Chung Shan Medical University Hospital

Zitieren

APA

Wang, X. A., Li, J. P., Wu, K. H., Yang, S. F., & Chao, Y. H. (2023). Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility. International Journal of Molecular Sciences, 24(5), 4464. https://doi.org/10.3390/ijms24054464

Vancouver

Wang XA, Li JP, Wu KH, Yang SF, Chao YH. Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility. International Journal of Molecular Sciences. 2023;24(5):4464. doi:10.3390/ijms24054464

BibTeX
@article{Wang2023,
  author = {Wang, Xing-An and Li, Ju-Pi and Wu, Kang-Hsi and Yang, Shun-Fa and Chao, Yu-Hua},
  title = {Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4464},
  doi = {10.3390/ijms24054464}
}
Kostenlos starten →